Quantcast Downing Ventures supports £4.6 million investment in Open Bionics, creator of the ‘hero arm’ | Downing
You may also find interesting
31 January 2019

The Downing UK Micro-Cap Growth Fund has re-opened to...

28 January 2019

Firefly, a suite of school learning tools used in 40...

Investment manager Downing exits five hydro projects
21 January 2019

Investment manager Downing LLP today announces the...

21 January 2019

Venture capital fund Downing Ventures has participated...

Downing Ventures supports £4.6 million investment in Open Bionics, creator of the ‘hero arm’

15 January 2019

Share article

Venture capital fund Downing Ventures has participated in a £4.6 million Series A funding round for developer of next-generation bionic limbs, Open Bionics. This follows on from an initial seed investment.

Open Bionics is an award-winning designer, manufacturer and supplier of bionic limbs, based at the University of the West of England in Bristol. The company uses 3D printing and scanning technology to produce custom-made prosthetics at a lower manufacturing cost than what is traditionally considered an expensive area of prosthetics. Its first commercial product, the Hero Arm, secured commercial licenses from Disney, Marvel and Pixar to design arms for children with themes from Star Wards, Frozen and the Marvel Universe.

Downing-managed funds have invested alongside Foresight Williams Technology EIS Fund, Ananda Impact Ventures and Rathbone Nominees. Osborne Clarke also advised on the deal.

Will Brooks, Investment Director at Downing Ventures, comments: “As early backers of Open Bionics, we are pleased to increase and strengthen our support for a talented team that’s bringing advanced prosthetics to a wider market. We believe in Open Bionics’ vision of democratising access to cutting-edge healthcare technology and look forward to helping the business make this a reality.”

Important Notice

Investing in our products will place your capital at risk and you may not get back the full amount invested. Any tax treatment may be subject to change and the availability and value of the reliefs depend on the individual circumstances of each investor. The availability of tax reliefs also depends on the investee companies maintaining their qualifying status.

Further information can be found at HMRC’s website. Neither past performance or forecasts are reliable indicators of future results and should not be relied upon. Unquoted or smaller company shares are likely to have higher price fluctuations and are likely to be more difficult to sell than shares quoted on the London Stock Exchange Official List. Website content is not intended to constitute investment, tax or legal advice. We recommend you seek independent advice before investing in any of our products.

Important Notice

Downing’s investments place your capital at risk and you may not get back the full amount invested. Past performance and forecasts are not a reliable guide to future results. Tax treatment may be subject to change and depends on individual circumstances. Smaller company shares are likely to have higher volatility and liquidity risks than other types of main market listed instruments. We recommend that you seek professional independent financial advice before investing. We do not offer investment or tax advice.

By clicking below you confirm you have read and understood the information above.